Vertex Pharmaceuticals Incorporated VRTX reported second-quarter 2024 results on Aug 1. Adjusted loss per share of $12.83 was wider than the Zacks Consensus Estimate of a loss of $11.50. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback